⌘K
t
Intuitive Investments Group plc (IIG) confirmed on 6 February 2024 that the Notice of Annual General Meeting (AGM), form of proxy, and Annual Report and Accounts for the year ended 30 September 2023 were posted to shareholders. The AGM is scheduled for 10:00 a.m. on 29 February 2024 and includes a proposed 10 existing ordinary shares for 1 new ordinary share consolidation of the Company's capital.
| Date | 6 Feb 2024 |
| Time | 10:45:03 |
| Category | AGMs and other meetings |
| ID | 1937C |
6 February 2024
Intuitive Investments Group plc
Posting of Annual Report and AGM Notice
Intuitive Investments Group plc (SFM: IIG) ("IIG" or the "Company"), the closed-end investment company focussed on fast growing and high potential opportunities in the Technology, Life Sciences and Healthcare sectors, confirms that the Notice of Annual General Meeting ("AGM"), form of proxy and Annual Report and Accounts for the year ended 30 September 2023 have been posted to shareholders.
An electronic copy of the Annual Report and Accounts and the Notice of AGM are available on the Company's website: https://iigplc.com/financial-reports/
The resolutions being proposed at the AGM include a proposed 10 existing ordinary shares for 1 new ordinary share consolidation of the share capital of the Company.
The Company's AGM will be held at the offices of FTI Consulting, 200 Aldersgate, Aldersgate Street, London EC1A 4HD at 10:00 a.m. on 29 February 2024, as an in-person meeting.
Shareholder participation and engagement is important to IIG, and the Company strongly encourages voting by proxy or in person.
Enquiries:
|
Intuitive Investments Group plc |
|
|
Sir Nigel Rudd, Non-Executive Chairman Robert Naylor, CEO Giles Willits, CIO
|
Via FTI Consulting |
|
SP Angel Corporate Finance LLP - Financial Adviser |
+44 (0) 20 3470 0470 |
|
Jeff Keating / David Hignell / Kasia Brzozowska
|
|
|
FTI Consulting |
+44 (0) 20 3727 1000 |
|
Jamie Ricketts / Valerija Cymbal / Jemima Gurney
|
IIG@fticonsulting.com |
About Intuitive Investments Group plc
IIG is an investment company seeking to provide investors with exposure to a portfolio concentrating on fast growing and/or high potential Life Sciences and Technology businesses operating predominantly in the UK, continental Europe, the US and APAC, utilising the Board's experience to seek to generate capital growth over the long term for shareholders.